A LGX 50mg Pill: beige orange, capsule/oblong, 22mm
Generic Name: encorafenib
The pill with imprint A LGX 50mg (Beige / Orange, Capsule/Oblong, 22mm) has been identified as Braftovi 50 mg and is used for Colorectal Cancer, Melanoma, Metastatic, and Non Small Cell Lung Cancer. It belongs to the drug class multikinase inhibitors and is not a controlled substance.
Images for A LGX 50mg
Braftovi
- Generic Name
- encorafenib
- Imprint
- A LGX 50mg
- Strength
- 50 mg
- Color
- Beige / Orange
- Size
- 22.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Array BioPharma Inc.
- National Drug Code (NDC)
- 70255-0020 (Discontinued)
- Inactive Ingredients
-
copovidone,
poloxamer 188,
microcrystalline cellulose,
succinic acid,
silicon dioxide,
magnesium stearate,
titanium dioxide,
ferric oxide red,
ferric oxide yellow,
ferrosoferric oxide,
shellac,
propylene glycol
Note: Inactive ingredients may vary.
See also:
More about Braftovi (encorafenib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.